Screening for future complementary health studies
Part of Pain clinical trials.
This is a screening study to see if you might be eligible for other research studies on complementary and integrative health approaches. It helps researchers determine if you can safely participate in future studies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 12 years of age or older.
- You must be willing to participate in research studies at the National Center for Complementary and Integrative Health.
- You should not have serious, uncontrolled health conditions like diabetes, heart failure, liver cirrhosis, or active cancer (other than common skin cancers).
- You should not have active mental health crises, such as severe mania or frequent panic attacks.
- You should not be using illicit drugs or have a substance use disorder.
- If you are female and could become pregnant, you must not be pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how accurately people can describe their pain and related symptoms. It may help researchers improve how pain is measured in future studies.
This study looks at how beliefs, mood, and social factors affect how people express and judge pain. It mainly uses pain/heat testing and—if chosen—brain scans to understand why pain reports can differ between people.
This study tests how people sense heat and pain, and how the brain and emotions may influence that experience. It is designed for healthy adults and may involve training sessions and (for some parts) MRI scanning.
This trial uses controlled, short-term pain testing (a “pain study”) to better understand how pain works during and after certain cancer treatments. It may help researchers improve how cancer therapy pain is measured and managed.
This is an early-stage study testing a new investigational drug called IG001119 in people who are in good health. Researchers will give increasing doses to small groups to learn how the drug is processed by the body and to check for any side effects.
This study looks at how stress and coping (“resilience”) may affect risk for pain. It may help researchers understand why some people develop ongoing, bothersome pain and how stress might play a role.
Hear when a new Pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.